INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
National Institutes of Health
Bethesda, Estados UnidosPublicaciones en colaboración con investigadores/as de National Institutes of Health (8)
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease
Nature Communications, Vol. 13, Núm. 1
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2019
-
A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency
Translational Research, Vol. 206, pp. 18-40
2015
-
Stem Cell Therapy for Corneal Epithelium Regeneration following Good Manufacturing and Clinical Procedures
BioMed Research International, Vol. 2015